| Literature DB >> 18350127 |
Taiwei Chu1, Zejun Li, Xinqi Liu, Xiangyun Wang.
Abstract
Timely imaging and accurate interpretation of cerebral ischemia are required to identify patients who might benefit from more aggressive therapy, and nuclear medicine offers a noninvasive method for demonstrating cerebral ischemia. Three nitroimidazole-based thioflavin-T derivatives, N-[4-(benzothiazol-2-yl)phenyl]-3-(4-nitroimidazole-1-yl) propanamide (4NPBTA), N-[4-(benzothiazol-2-yl)phenyl]-3-(4-nitroimidazole-1-yl)-N-methylpropanamide (4NPBTA-1), and N-[4-(benzothiazol-2-yl)phenyl]-3-(2-nitroimidazole-1-yl) propanamide (2NPBTA), were radioiodinated and evaluated as possible cerebral ischemia markers. In normal mice, these compounds showed good permeation of the intact blood-brain barrier (BBB), high initial brain uptake, and rapid washout. In gerbil stroke models that had been subjected to right common carotid artery ligation to produce cerebral ischemia, [(131)I]2NPBTA, uptake in the right cerebral hemisphere decreased more slowly than that of the left, and the right/left hemisphere uptake ratios increased with time. Also, the right/left hemisphere uptake ratios correlated positively with the severity of the stroke. The results showed that [(131)I]2NPBTA had a specific location in the cerebral ischemic tissue. This represented a first step in finding new drugs and might provide a possible cerebral ischemic marker.Entities:
Year: 2007 PMID: 18350127 PMCID: PMC2267214 DOI: 10.1155/2007/49791
Source DB: PubMed Journal: Int J Biomed Imaging ISSN: 1687-4188
Figure 1Structures of [131I]2NPBTA, [131I]4NPBTA, and [131I]4NPBTA-1.
Brain uptake and clearance.
| Compound | 2 min (ID%/g) | 30 min (ID%/g) | Ratio of 2-to-30 min |
|---|---|---|---|
| [131I]2NPBTA | 2.93 ± 0.39 | 0.47 ± 0.11 | 6.2 |
| [131I]4NPBTA | 2.90 ± 0.31 | 0.30 ± 0.10 | 9.7 |
| [131I]4NPBTA-1 | 3.31 ± 0.50 | 0.61 ± 0.16 | 5.4 |
Uptake in the gerbil ischemic and normal brain hemisphere (%ID/g).
| Brain | [131I]2NPBTA | [131I]4NPBTA | [131I]4NPBTA-1 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4 h | 8 h | 12 h | 4 h | 8 h | 12 h | 4 h | 8 h | 12 h | |
| Right | 0.042 ± 0.005 | 0.034 ± 0.006 | 0.025 ± 0.004* | 0.046 ± 0.006 | 0.022 ± 0.001 | 0.020 ± 0.004 | 0.040 ± 0.008 | 0.017 ± 0.001 | 0.015 ± 0.002 |
| Left | 0.036 ± 0.004 | 0.025 ± 0.003 | 0.014 ± 0.002 | 0.038 ± 0.001 | 0.018 ± 0.005 | 0.016 ± 0.003 | 0.034 ± 0.010 | 0.013 ± 0.002 | 0.012 ± 0.002 |
| Right/Left | 1.18 ± 0.13 | 1.39 ± 0.10(**) | 1.76 ± 0.10(***) | 1.22 ± 0.16 | 1.28 ± 0.28(**) | 1.24 ± 0.03(*) | 1.18 ± 0.02 | 1.26 ± 0.28(**) | 1.27 ± 0.13(**) |
Each value is mean ± SD
(*).05>P value >.01 as compared with left brain.
(**)P value >.05 as compared with 4 hours.
(***)P value <.01 as compared with 4 hours.
Figure 2The uptake of [131I]2NPBTA in coronal brain slices (designated A, B, C, D, E from rostral to caudal ends) from 4 gerbils subjected to right common carotid ligation after repetitive administration. The coronal slices stroke index (SI) was indicated above the histograms.